Clada Medical licenses Limerick's technology
14/04/2012
Novel technology for use in angioplasty invented by researchers at the University of Limerick (UL) has been licensed to Galway-based medical device company Clada Medical.
The device will improve
success rates of angioplasty procedures. It is estimated that more than 1
million angioplasty procedures are undertaken worldwide each year and the value
of products relating to this procedure is in the region of €500 million.
During angioplasty, particles
of the fatty deposits can become dislodged and enter the blood stream, which
can block other arteries resulting in strokes or heart attacks. Embolic
protection devices are often used to capture and remove the dislodged fatty
deposits.
The UL device combines angioplasty balloon and embolic protection
technologies allowing for continuous blood flow during the procedure.
Irish-owned Clada Medical provides
medical device design, research and development, testing and OEM manufacturing
services from its Class 8 clean-room facilities in Galway. The company has
particular expertise in balloon mould manufacturing and custom balloon/catheter
design.
Ray Blowick, the company’s
CEO, said, "The application of the UL invention to perfusion balloon technology
is very important for the future of our company. Our commercial strategy
includes growing our company through the development and licensing of new
technologies, which will lead to new jobs and increased exports in this
important sector for Irish industry.”
Related News
Limerick’s angioplasty success
09/05/2012
A novel technology invented by researchers at the University of Limerick (UL) will improve success rates in angioplasty procedures.... read more >
University of Limerick in nanomaterials project
10/04/2012
Scientists from the University of Limerick have joined an EC funded project to assess and manage potential risks associated with nanomaterials.... read more >
